Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Recombinant human arylsulfatase A

EU orphan designation number: EU/3/03/158
Active ingredient: Recombinant human arylsulfatase A
Indication: Treatment of metachromatic leukodystrophy
Sponsor: Shire Pharmaceuticals Ireland Limited
5 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/07/2003 Orphan designation EMEA/OD/024/03 (2003)2569 of 09/07/2003
04/02/2005 Change of name and/or address of sponsor
30/06/2008 Transfer of orphan designation EMEA/OD/024/03/T/01 (2008)3295 of 25/06/2008
28/09/2011 Removal of orphan designation from Community Register